Vestand Loses Nasdaq Listing, Falls to OTC Pink After Failed Appeal
VSTD has more than doubled off its 52-week low of $0.013 on elevated volume (5.4× avg).
Summary
Vestand Inc. has been delisted from Nasdaq effective July 27, 2026, after the Hearings Panel rejected its appeal. The stock now trades on the OTC Pink market, marking a severe blow to the company's credibility and liquidity.
Key Events · Legal and Risk Events · VSTD
-
Nasdaq Delisting Finalized
On July 23, 2026, Nasdaq's Hearings Panel issued a final decision to delist Vestand's Class A Common Stock, effective July 27, 2026, after the company failed to regain compliance with periodic reporting and minimum bid price requirements.
-
Stock Moves to OTC Pink
Trading began on the OTC Pink Limited Market under symbol VSTD on July 27, 2026, significantly reducing liquidity and institutional accessibility.
-
Panel Cites Deep Concerns
The Panel highlighted the prolonged absence of public disclosure, a change in the company's business, and reservations about Vestand's experience and institutional stability as reasons for the delisting.
-
Appeal Window Open
Vestand has 15 calendar days from July 23 to request a review by the Nasdaq Listing and Hearing Review Council, but there is no assurance it will do so or that the decision will be reversed.
Analysis · VSTD · Trade & Services
Nasdaq's final delisting decision cuts Vestand off from a major exchange, forcing its stock to the less liquid OTC Pink market. The Panel cited prolonged reporting failures and doubts about the company's stability. This caps a months-long compliance crisis and raises serious questions about the company's ability to regain investor confidence or access capital.
At the time of this filing, VSTD was trading at $0.06 on OTC in the Trade & Services sector, with a market capitalization of approximately $284.5K. The 52-week trading range was $0.01 to $2.48. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.